Not currently approved for paediatric use
Not currently approved for maintenance in people who are 65 years old or older.
Women with inflammatory bowel disease should discontinue ozanimod at least 3 months prior to conception unless there is no effective alternative therapy to maintain maternal health.17
Mothers currently on S1P receptor modulators should not breastfeed.17